Dr Caroline Sayer
Caz has had a long-standing and varied clinical career including experience as a partner in general practice for over 30 years, setting up a company (Haverstock Healthcare Ltd) to deliver community-based services and as the elected and appointed chair of Camden Clinical Commissioning Group (CCG) from its commencement in 2011 until 2017 when she completed her two elected terms. While Chair of Camden CCG she sought to establish a ‘value-based’ approach to commissioning healthcare leading the establishment of a range of community-based services integrating health and social care, underpinned by the development of a population health management tool segmenting the population by need and driven by patient-defined outcomes. The impact of this approach resulted in measurably improved outcomes for patients and reduced hospital usage with Camden performing above top decile for non-elective admissions.
She is currently developing a new role focussing on primary care workforce development and education and supporting implementation of new models of care alongside working through and establishing links with a range of organisations influencing health policy.
Caz’s wider involvement has ranged across a number of contributions (through inclusion on London Health Commission Board), various publications (most recently NEJM Catalyst ‘Towards Accountable Care: Achieving Value and Integration Via Population Health management’) to numerous national and international presentations including Hong Kong Health Convention 2015, Scottish Parliament 2015, Kings Fund 2016, European Innovations and Technology (EIT) 2017, FTI ‘Value-based contracting’ South Africa 2018.
Dr Stephanie Baldeweg
Dr Stephanie Baldeweg is a Consultant Physician in Diabetes and Endocrinology at University College London Hospital and Honorary Senior Lecturer in the Department of Medicine at UCL. She graduated from Humboldt University, Berlin in 1990 and undertook her Specialist Training in London. She was awarded the MD for the thesis on “Insulin resistance and endothelial function in health and type 2 diabetes”. Dr Baldeweg is the Training Program Director for the North Thames Rotation in Diabetes and Endocrinology. She regularly lectures at national and international meetings as well as Patient days for Support groups such as Diabetes UK and the Pituitary Foundation. She was made a Fellow of the Royal College of Physicians of Ireland in March 2009 (FRCPI) and a Fellow of the Royal College of Physicians (London) in June 2009 (FRCP).
Dr Baldeweg is interested in all aspects of diabetes and endocrinology. She has a special clinical and research interest in pituitary disease. Her other interests include diabetes, thyroid and reproductive as well as osteoporosis, weight management and cardiovascular risk reduction. She also has an interest in pregnancy preparation for women with diabetes and endocrine disease.
Dr Caroline Smith
Caroline qualified Charing Cross Hospital 1984 and has been a GP for 28 years in West Sussex in various roles including GP partner for 21 years. Caroline is currently working as portfolio GP – part time Partner, GP educator and appraiser, a role she has undertaken for NHSE for 15 years involved appraising and re-validating GPs in West Sussex.
She has been a GP trainer for 11 years including being Brighton VTS Programme Director for 4 years running, developing educational programme for GP registrars in Brighton and Mid -Sussex, Caroline has formulated and delivered educational support and development of GP trainers and been involved in GP recruitment assessment days and ARCP for HEEKSS.
Professor Derek Yellon
Derek M Yellon PhD, DSc (UK), DSc (UCT), FRCP (Hon), FACC, FESC, FAHA, is Professor of Molecular & Cellular Cardiology at University College London (UCL) & Director of the Hatter Cardiovascular Institute at UCL Hospitals & Medical School. He is also Programme Director (Cardiology & Diabetes) for the NIHR-UCLH Biomedical Research Centre.
He is past Vice President of the British Cardiovascular Society and past Chairman of the Cellular Biology Working Group of the European Society of Cardiology as well as past member of the World Council of the International Society for Heart Research. He was recently elected to Department of Health’s National Institute for Health Research (NIHR) as a Senior Investigator as well as a member of the College of Senior Investigators. In 1994 he was awarded a DSc for his “substantial contribution to the knowledge of cardiovascular disease and treatment”. In 2013 been awarded a second Doctor of Science (honorius causa) degree from the University of Cape Town in recognition of his distinguished basic and clinical research in the mechanisms underlying myocardial protection.
Professor Yellon was instrumental in establishing the Hatter Cardiovascular Institute at the Medical School of the University of Cape Town. In recognition of these achievements he was, in 1997, made an Hon. Professor in the Department of Medicine at the University of Cape Town. He also holds Honorary Professorships at the University of South Alabama in the USA, and the North China Coal Medical University in China.
He is a Fellow of the Royal College of Physicians; the American College of Cardiology; the European Society of Cardiology; the International Society for Heart Research and the American Heart Association.
He is on the editorial board of a number of major Cardiovascular Journals and has published in excess of 500 full papers and edited 23 books. He runs a translational research Institute with his main area of interest including; myocardial protection, the pathophysiology of cardioprotection in the setting of diabetes, ischaemia/reperfusion injury, molecular aspects of adaptation to ischaemic injury and myocardial conditioning in both the basic and clinical arena.
Professor John Cunningham
John Cunningham is a clinician-scientist holding positions as Professor of Nephrology at University College London Medical School and The Royal Free Hospital and an Honorary Fellowship at Trinity Hall, University of Cambridge, both in the UK. His early training was in Cambridge (pre-clinical) and Oxford, UK (clinical), with postgraduate training at The University of London and Washington University School of Medicine, St Louis, USA under Drs Louis V Avioli and Eduardo Slatopolsky. He has remained an active frontline clinician in both nephrology and internal medicine. John Cunningham was Physician to HM The Queen and was knighted for services to The Royal Family in June 2014.
Academically Professor Cunningham has contributed to the understanding of the effect of acidosis on the bioactivation of vitamin D and described and characterised hysteresis in the parathyroid response to calcium, indicating that parathyroid cells can sense both the direction of change and the absolute concentration of ECF calcium. He subsequently ran research programmes examining the following: control by structurally modified vitamin D metabolites at PTH synthesis and release; the synthesis and release of bone cytokines by osteoblast like cells and the regulation of these by vitamin D metabolites; the location and relevance of the calcium sensing receptor in bone cells; the influence of simulated uraemia on the release of cytokines by bone cells; the factors mediating bone loss following renal transplantation and preventative strategies; the factors that control parathyroid function in vivo, including new vitamin D metabolites and calcimimetic agents. Professor Cunningham’s group has found that new structurally modified metabolites of vitamin D differ markedly in the way they influence the behaviour of both parathyroid cells and bone cells. His group also devised, conducted and published studies of the first effective prophylaxis against bone loss in the post transplant setting. On these and other subjects, Professor Cunningham frequently lectures nationally and internationally, as well as serving on numerous international expert panels and working groups. He is a founding Co-chairman of the Nephrology At The Limits series held under the auspices of University College London, The University of Cape Town, and The Lancet.
Dr Richard Horton
Richard Horton is Editor-in-Chief of The Lancet. He was born in London and is half Norwegian. He qualified in physiology and medicine with honours from the University of Birmingham in 1986. He joined The Lancet in 1990, moving to New York as North American Editor in 1993. Richard was the first President of the World Association of Medical Editors and he is a Past-President of the US Council of Science Editors. He is an honorary professor at the London School of Hygiene and Tropical Medicine, University College London, and the University of Oslo. He has received honorary doctorates in medicine from the University of Birmingham, UK, and the Universities of Gothenburg and Umea in Sweden. In 2016, he was appointed to the High-Level Working Group for the Health and Human Rights of Women, Children, and Adolescents.
In 2016, he also chaired the Expert Group for the High Level Commission on Health Employment and Economic Growth, convened by Presidents Hollande of France and Zuma of South Africa. From 2011 to 2015, he was co-chair of the UN’s independent Expert Review Group on Information and Accountability for Women’s and Children’s Health. Richard received the Edinburgh Medal in 2007 and the Dean’s Medal from Johns Hopkins School of Public Health in 2009. In 2016, he was awarded an Honorary Fellowship by the British Pharmacological Society. He has written two reports for the Royal College of Physicians of London: Doctors in Society (2005) and Innovating for Health (2009). He wrote Health Wars (2003) about contemporary issues in medicine and health, and he has written for The New York Review of Books and the TLS. He has a strong interest in global health and medicine’s contribution to our wider culture. He now works to develop the idea of planetary health – the health of human civilizations and the ecosystems on which they depend. In 2011, he was elected a Foreign Associate of the US Institute of Medicine. In 2015, he received the Friendship Award from the Government of China. In 2016, he received the Andrija Stamper medal from the Association of Schools of Public Health in the European region and in 2017, he was awarded the Edwin Chadwick Medal for outstanding contributions to the advancement of public health.
The meeting is supported by educational grants and sponsorship from the Pharmaceutical Industry. Supporters who have provided support for this programme have had no editorial control or influence of the content of the meeting. Further information can be found here: https://horizonseries.org/hgp-2019/supporters/